• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Indian company to make generic version of flu drug Tamiflu

      Posted AtThe New York Times

      A major Indian drug company announced yesterday that it would start making a generic version of Tamiflu, the anti-influenza drug that is in critically short supply in the face of a possible epidemic of avian flu.

      "Right or wrong, we're going to commercialize and make oseltamivir," said Dr. Yusuf K. Hamied, chairman of Cipla of Bombay, using the drug's generic name and acknowledging that he might face a fight in the Indian courts with Roche, the Swiss pharmaceutical giant that holds the patent.

      Although generic manufacturers cannot legally sell the patented drug in the West, all national patent laws, including those of the United States, allow governments to cancel patents during emergencies and either buy generics or force patent holders to license their formulas to rivals.

      A spokeswoman for the Department of Health and Human Services, which has recently ordered 12.3 million doses of Tamiflu from Roche, said she could not comment on the effect of Cipla's announcement. "Preparing the world for a pandemic flu outbreak is a top priority, and we're looking at various options in stockpiling drugs and vaccine," said the spokeswoman, Christina Pearson. "But there are a lot of issues, and it's too early to speculate about this right now."

      Roche has been under growing pressure from several countries and the United Nations secretary general, Kofi Annan, to license generic versions of the drug, which eases flu's worst symptoms.

      The company, which sells Tamiflu for $60 per treatment in the United States, has repeatedly refused to license the generic version, or even to disclose how much it makes, other than saying it plans to increase production "eightfold." A Roche spokesman, Terry Hurley, said yesterday that the company "fully intends to remain the sole manufacturer of Tamiflu."

      Making the drug involves 10 complex steps, he said, and the company believes that it will take another company "two to three years, starting from scratch," to produce it.

      Dr. Hamied dismissed that claim, saying that he initially thought it would be too hard but that his scientists had finished reverse-engineering the drug in his laboratories two weeks ago. He said he could have small commercial quantities available as early as January.

      Asked if he thought Dr. Hamied was making an idle boast, Mr. Hurley declined to comment. Cipla, India's third-largest drug maker, has copied dozens of Western drugs, including Lipitor and Viagra, and produces raw ingredients for Western drug companies. Its inexpensive H.I.V. drugs, approved by the World Health Organization, are used by 400,000 people worldwide.Dr. Hamied said he would sell generic Tamiflu "at a humanitarian price" in developing nations and not aim at the American or European market. "God forbid the avian flu should strike India," he said. "There is no line of defense." Under Indian patent laws, which were tightened in March, he believes that he can sell the drug in India and in 49 other countries rated "least developed" by the United Nations.

      The new law recognizes patents filed by Western companies after Jan. 1, 1995, and the Tamiflu patent in India was filed with a "priority date" of Feb. 26, 1995. Dr. Hamied said he thought the Indian government would be unlikely to fight over a 10-year-old difference of two months, especially if the lives of millions of Indians were at stake.

      Scientists in Taiwan and other countries have said they, too, can produce generic Tamiflu, if patent issues are resolved.

      Mr. Hurley declined to say whether Roche would fight Cipla in court, but said, "If we determine that there has been an infringement, we'd move to protect our rights and interests."

      October 14, 2005


       

      Share this Article!

    Back to top^